InductOs

DRUG2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer, University of Zurich

Conditions

Missing TeethTibial Fractures

Phase 3

Lateral Ridge Augmentation Using Autogenous Bone Blocks or Xenogenic Bone Block Grafts Loaded With Recombinant Human Bone Morphogenic Protein 2

CompletedNCT01541345

University of ZurichMissing Teeth

Start: 2011-02-28End: 2019-06-04Updated: 2021-12-02

Phase 4

Study Evaluating InductOs in Diaphyseal Tibia Fractures

CompletedNCT00161616

Wyeth is now a wholly owned subsidiary of PfizerTibial Fractures

Start: 2003-09-30End: 2008-08-31Updated: 2009-09-07